Squarepoint’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 2741 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2769 |
|
|
2024
Q3 | – | Sell |
-252,793
| Closed | -$6.4M | – | 2550 |
|
|
2024
Q2 | $6.4M | Buy |
+252,793
| New | +$6.4M | 0.01% | 606 |
|
|
2024
Q1 | – | Sell |
-79,999
| Closed | -$3.23M | – | 2447 |
|
|
2023
Q4 | $3.23M | Sell |
79,999
-87,527
| -52% | -$3.53M | 0.01% | 829 |
|
|
2023
Q3 | $4.42M | Sell |
167,526
-89,572
| -35% | -$2.36M | 0.01% | 650 |
|
|
2023
Q2 | $4.42M | Buy |
257,098
+9,530
| +4% | +$164K | 0.01% | 598 |
|
|
2023
Q1 | $4.1M | Buy |
247,568
+210,814
| +574% | +$3.5M | 0.02% | 579 |
|
|
2022
Q4 | $280K | Sell |
36,754
-248,912
| -87% | -$1.9M | ﹤0.01% | 1732 |
|
|
2022
Q3 | $2.84M | Buy |
285,666
+165,973
| +139% | +$1.65M | 0.01% | 645 |
|
|
2022
Q2 | $1.09M | Sell |
119,693
-23,489
| -16% | -$213K | 0.01% | 1001 |
|
|
2022
Q1 | $1.45M | Buy |
143,182
+54,711
| +62% | +$555K | 0.01% | 963 |
|
|
2021
Q4 | $1.48M | Buy |
88,471
+43,896
| +98% | +$732K | ﹤0.01% | 1024 |
|
|
2021
Q3 | $2.09M | Buy |
44,575
+2,692
| +6% | +$126K | 0.01% | 769 |
|
|
2021
Q2 | $2.55M | Buy |
41,883
+19,755
| +89% | +$1.2M | 0.01% | 704 |
|
|
2021
Q1 | $1.36M | Buy |
22,128
+1,806
| +9% | +$111K | 0.01% | 902 |
|
|
2020
Q4 | $1.45M | Buy |
20,322
+4,727
| +30% | +$336K | 0.01% | 891 |
|
|
2020
Q3 | $585K | Sell |
15,595
-1,741
| -10% | -$65.3K | 0.01% | 1235 |
|
|
2020
Q2 | $565K | Buy |
+17,336
| New | +$565K | 0.01% | 1241 |
|